Skip to main content
Caplight Logo









CS Pharmaceuticals

CS Pharmaceuticals

Private
LondonHealthcare & Life Scienceshttps://cspharmaceuticals.com/

Last Round

Corporate Funding

Nov 22, 2021

Total Funding Raised

$4.96M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CS Pharmaceuticals is a pharmaceuticals company that develops and commercialises innovative ophthalmology, rare and speciality disease products to address high unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

pharma in-licensingdrug commercializationChina pharma market accessspecialty pharmaophthalmology drugsrare disease drugspharma licensing partnerChina drug regulatorylate-stage drug developmentChina pharma bridgemarket access servicesdry eye disease treatmentMeibomian Gland Dysfunctionidiopathic pulmonary fibrosiscystic fibrosis treatmentNational Reimbursement Drug ListNRDL

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CS Pharmaceuticals Comparables

Compare CS Pharmaceuticals with similar companies based on industry and business-model similarity.

CS Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sperogenix Therapeutics
79%
Arctic Vision
71%
Hasten Biopharmaceutical Co., Ltd.
66%

CS Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 22, 2021
SeedJun 1, 2021

Key People

Founding team and executive leadership

Darren Mercer

Chief Executive Officer

Executive Team

CS Pharmaceuticals Investors

Notable investors and investment history

CS Pharmaceuticals investors
InvestorRounds
Downing VenturesCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 368% MoM, from 235 to 1.1K.

  • May 17, 2026

    Monthly visitors increased 36% MoM, from 803 to 1.1K.

CS Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

CS Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CS Pharmaceuticals's valuation, stock price, and market status.

Is CS Pharmaceuticals a public or private company?

CS Pharmaceuticals is a private company.

What is the current stock price of CS Pharmaceuticals?

CS Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is CS Pharmaceuticals worth (valuation)?

Valuation information for CS Pharmaceuticals is not publicly available.

Can I buy CS Pharmaceuticals stock?

CS Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CS Pharmaceuticals's last funding round?

Funding round information for CS Pharmaceuticals is not publicly available.

Who are the main investors in CS Pharmaceuticals?

Investor information for CS Pharmaceuticals is not publicly disclosed.

Will CS Pharmaceuticals IPO soon?

No public IPO plans have been announced for CS Pharmaceuticals.

How can I track CS Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CS Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range4
Year Founded2020
Last FundingNov 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?